PharmaShots | Incisive News in 3 Shots

Subscribe Now

HoFH

Regeneron Reports the US FDA's Acceptance of Evinacumab's BLA for Priority Review as a Treatment for Patients with HoFH

Regeneron Reports the US FDA's Acceptance of Evinacumab's BLA for Priority Review as a Treatment for Patients with HoFH

August 13, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us